<DOC>
	<DOCNO>NCT00477048</DOCNO>
	<brief_summary>Efficacy safety saquinavir ( SQV ) base regimen HIV-1 infect Thai patient chronic indinavir ( IDV ) associate nephrotoxicity .</brief_summary>
	<brief_title>Efficacy Safety SQV Patients Who Have Chronic IDV Nephrotoxicity</brief_title>
	<detailed_description>Primary objective : To determine whether switch SQV cause improvement renal function patient chronic IDV associate nephrotoxicity without improvement IDV dose reduction . Secondary objective : 1 . To describe pathophysiology chronic IDV associate renal impairment renal biopsy baseline week 48 2 . To describe pathophysiology chronic IDV associate renal impairment renal tubular function baseline week 48 3 . To determine whether switch SQV cause improvement renal pathophysiology patient chronic IDV associate nephrotoxicity renal biopsy perform baseline week 48 4 . To determine whether switch SQV result improvement hypertension , lipid profile cutaneous side effect</detailed_description>
	<mesh_term>Saquinavir</mesh_term>
	<criteria>IDV contain regimen 1 year creatinine 1.4 least 6 months/abnormal renal imaging/abnormal urinary examination Viral load le 50 copy Saquinavir intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>IDV nephrotoxicity</keyword>
</DOC>